Short Interest in ASP Isotopes Inc. (NASDAQ:ASPI) Grows By 52.1%

ASP Isotopes Inc. (NASDAQ:ASPI) was the recipient of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 722,000 shares, a growth of 52.1% from the March 31st total of 474,600 shares. Based on an average trading volume of 638,000 shares, the days-to-cover ratio is presently 1.1 days. Currently, 3.2% of the company’s stock are sold short.

Hedge Funds Weigh In On ASP Isotopes

An institutional investor recently bought a new position in ASP Isotopes stock. Rathbones Group PLC bought a new stake in shares of ASP Isotopes Inc. (NASDAQ:ASPI) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 151,750 shares of the company’s stock, valued at approximately $272,000. Rathbones Group PLC owned about 0.31% of ASP Isotopes at the end of the most recent reporting period. 16.80% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright lifted their target price on shares of ASP Isotopes from $5.25 to $5.50 and gave the company a “buy” rating in a research note on Wednesday, April 17th.

ASP Isotopes Trading Up 1.8 %

NASDAQ:ASPI opened at $3.44 on Monday. ASP Isotopes has a 12 month low of $0.28 and a 12 month high of $4.97. The firm has a market cap of $168.28 million, a price-to-earnings ratio of -7.02 and a beta of 5.03. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.01. The company’s 50 day moving average is $3.71 and its 200-day moving average is $2.50.

ASP Isotopes (NASDAQ:ASPI) last released its quarterly earnings results on Wednesday, April 10th. The company reported ($0.09) EPS for the quarter. The firm had revenue of $0.43 million for the quarter. Equities analysts anticipate that ASP Isotopes will post -0.11 EPS for the current year.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.